CEL-SCI Corporation Announces Proposed Public Offering of Common Stock and Warrants

CEL-SCI Corporation (NYSE: CVM ), a late-stage oncology company, today announced that it intends to offer and sell common stock and warrants in an underwritten public offering. The offering is subject to market conditions, and there can be no assurance as to whether or when the offering may be